The Menlo Park, California-based Facebook Inc (NASDAQ:FB) informed regulators before its debut that the planned price range reflected the fair worth forecasted prior current year.
The United States Securities and Exchange Commission reported on Friday that Facebook, which has lost over $19 billion in market value since its IPO, set a planned Initial Public price range of $28 to $35 per share on April 25, derived from the estimated fair value of $30.89.
Facebook added $16 billion in the May 17 Initial Public Offering, the prime ever IPO for a technology or Internet corporation. Shares of world’s biggest social networking site plunged on fears that ad revenue growth was not able to maintain the pace with boosting membership as more users access the site on mobile phones.
Shifting readers focus to broader market, let’s consider market performance of other stocks that significantly affect same sector. Renren Inc (NYSE:RENN) moves up +1.12% to settle at $4.51, Zynga Inc (NASDAQ:ZNGA) moved up +10.65% to end at $5.56 while Groupon Inc (NASDAQ:GRPN) increased +6.68% to finish on Friday at $10.06.
Facebook Inc (NASDAQ:FB) last session volume of 43.56 million shares was surprisingly lower than its average volume of 81.30 million shares. The stock after opening at $28.50 hit high price of $30.10 and then closed at $30.01 by scoring +6.09%.
FB generated revenue of 3.71 billion in the following twelve months and earned $668.00 million. The Company showed a positive +26.95% in the net profit margin and as well as in its operating margin which remained +47.32%.
The FB past twelve months price to sales ratio was 17.29 and price to cash ratio remained 16.41. The stock showed weekly upbeat performance of +10.75% while the YTD performance remained at -21.49%.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL